Moderna Inc. (NASDAQ: MRNA) shares dipped on Wednesday after the company announced a new deal with the U.S. government for its COVID-19 vaccine. Although shares pulled back, this appears be a case of “sell the news,” because this is ultimately a net positive for the company.
Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S. government’s goal of securing early access to safe and effective COVID-19 vaccines for the American people.
As a result, the company was awarded up to $1.525 billion for the manufacturing and delivery of these 100 million vaccines. This award includes incentive payments for the timely delivery of the product. The previous award was up to $955 million from the Biomedical Advanced Research and Development Authority (BARDA) for the development of mRNA-1273 to licensure.
This announcement brings the U.S. government commitments for early access to the vaccine up to $2.48 billion.
Under the terms of the agreement, the U.S. government, as a part of Operation Warp Speed, also will have the option to purchase up to an additional 400 million doses of mRNA-1273 from Moderna.
One key part of this is that the U.S. government has announced that consistent with its commitment to free access to COVID-19 vaccines, Americans will receive mRNA-1273 at no cost for the vaccine itself. However, there may be costs associated with administering the vaccine.
Management also was quick to note that it is advancing the clinical development of mRNA-1273, with the ongoing Phase 3 study being conducted in collaboration with National Institute of Allergy and Infectious Diseases and BARDA. At the same time, Moderna is scaling up its manufacturing capability with its strategic partners.
Note that Moderna has posted gains of roughly 252% so far in 2020. Investors looking to realize gains could be pushing the stock down on Wednesday.
Moderna stock was last seen down about 1%, at $68.31 in a 52-week range of $12.47 to $95.21. The consensus price target is $93.77.
Credit Card Companies Are Doing Something Nuts
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.